Cargando…
PB1849: EARLY SALVAGE THERAPY WITH VENETOCLAX AND 10-DAY DECITABINE IS FEASIBLE AND SAFE IN REFRACTORY AML: RESULTS FROM 11 PATIENTS WITH EARLY INDUCTION FAILURE
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430234/ http://dx.doi.org/10.1097/01.HS9.0000974236.99884.c7 |
| _version_ | 1785090912810958848 |
|---|---|
| author | Borst, Carla Ginsberg, Franziska Weller, Jan Vogel, Wichard Faul, Christoph Bethge, Wolfgang Christopeit, Maximilian Lengerke, Claudia |
| author_facet | Borst, Carla Ginsberg, Franziska Weller, Jan Vogel, Wichard Faul, Christoph Bethge, Wolfgang Christopeit, Maximilian Lengerke, Claudia |
| author_sort | Borst, Carla |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430234 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104302342023-08-17 PB1849: EARLY SALVAGE THERAPY WITH VENETOCLAX AND 10-DAY DECITABINE IS FEASIBLE AND SAFE IN REFRACTORY AML: RESULTS FROM 11 PATIENTS WITH EARLY INDUCTION FAILURE Borst, Carla Ginsberg, Franziska Weller, Jan Vogel, Wichard Faul, Christoph Bethge, Wolfgang Christopeit, Maximilian Lengerke, Claudia Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430234/ http://dx.doi.org/10.1097/01.HS9.0000974236.99884.c7 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Borst, Carla Ginsberg, Franziska Weller, Jan Vogel, Wichard Faul, Christoph Bethge, Wolfgang Christopeit, Maximilian Lengerke, Claudia PB1849: EARLY SALVAGE THERAPY WITH VENETOCLAX AND 10-DAY DECITABINE IS FEASIBLE AND SAFE IN REFRACTORY AML: RESULTS FROM 11 PATIENTS WITH EARLY INDUCTION FAILURE |
| title | PB1849: EARLY SALVAGE THERAPY WITH VENETOCLAX AND 10-DAY DECITABINE IS FEASIBLE AND SAFE IN REFRACTORY AML: RESULTS FROM 11 PATIENTS WITH EARLY INDUCTION FAILURE |
| title_full | PB1849: EARLY SALVAGE THERAPY WITH VENETOCLAX AND 10-DAY DECITABINE IS FEASIBLE AND SAFE IN REFRACTORY AML: RESULTS FROM 11 PATIENTS WITH EARLY INDUCTION FAILURE |
| title_fullStr | PB1849: EARLY SALVAGE THERAPY WITH VENETOCLAX AND 10-DAY DECITABINE IS FEASIBLE AND SAFE IN REFRACTORY AML: RESULTS FROM 11 PATIENTS WITH EARLY INDUCTION FAILURE |
| title_full_unstemmed | PB1849: EARLY SALVAGE THERAPY WITH VENETOCLAX AND 10-DAY DECITABINE IS FEASIBLE AND SAFE IN REFRACTORY AML: RESULTS FROM 11 PATIENTS WITH EARLY INDUCTION FAILURE |
| title_short | PB1849: EARLY SALVAGE THERAPY WITH VENETOCLAX AND 10-DAY DECITABINE IS FEASIBLE AND SAFE IN REFRACTORY AML: RESULTS FROM 11 PATIENTS WITH EARLY INDUCTION FAILURE |
| title_sort | pb1849: early salvage therapy with venetoclax and 10-day decitabine is feasible and safe in refractory aml: results from 11 patients with early induction failure |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430234/ http://dx.doi.org/10.1097/01.HS9.0000974236.99884.c7 |
| work_keys_str_mv | AT borstcarla pb1849earlysalvagetherapywithvenetoclaxand10daydecitabineisfeasibleandsafeinrefractoryamlresultsfrom11patientswithearlyinductionfailure AT ginsbergfranziska pb1849earlysalvagetherapywithvenetoclaxand10daydecitabineisfeasibleandsafeinrefractoryamlresultsfrom11patientswithearlyinductionfailure AT wellerjan pb1849earlysalvagetherapywithvenetoclaxand10daydecitabineisfeasibleandsafeinrefractoryamlresultsfrom11patientswithearlyinductionfailure AT vogelwichard pb1849earlysalvagetherapywithvenetoclaxand10daydecitabineisfeasibleandsafeinrefractoryamlresultsfrom11patientswithearlyinductionfailure AT faulchristoph pb1849earlysalvagetherapywithvenetoclaxand10daydecitabineisfeasibleandsafeinrefractoryamlresultsfrom11patientswithearlyinductionfailure AT bethgewolfgang pb1849earlysalvagetherapywithvenetoclaxand10daydecitabineisfeasibleandsafeinrefractoryamlresultsfrom11patientswithearlyinductionfailure AT christopeitmaximilian pb1849earlysalvagetherapywithvenetoclaxand10daydecitabineisfeasibleandsafeinrefractoryamlresultsfrom11patientswithearlyinductionfailure AT lengerkeclaudia pb1849earlysalvagetherapywithvenetoclaxand10daydecitabineisfeasibleandsafeinrefractoryamlresultsfrom11patientswithearlyinductionfailure |